August 4, 2021

Aro Biotherapeutics Expands Leadership Team and Plans Move to New Philadelphia Headquarters to Drive Next Phase of Growth

February 24, 2021

Aro Biotherapeutics Expands Leadership Team with Addition of Proven Scientific Executives

January 5, 2021

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines